Oncolytics Biotech (ONCY)
(Delayed Data from NSDQ)
$1.09 USD
+0.03 (2.83%)
Updated May 24, 2024 04:00 PM ET
After-Market: $1.08 -0.01 (-0.92%) 4:40 PM ET
2-Buy of 5 2
D Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.08 | 0.00% |
Earnings Summary
For their last quarter, Oncolytics Biotech (ONCY) reported earnings of -$0.07 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 22.22%. Look out for ONCY's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.08 per share, reflecting a year-over-year increase of 11.11%.
Earnings History
Price & Consensus
Zacks News for ONCY
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
ONCY: What are Zacks experts saying now?
Zacks Private Portfolio Services